Camlin Fine Sciences Limited has accepted the resignation of Mr. Anvarhusen Bilakhiya from the position of Vice President - Principal Scientist (R&D), effective July 7, 2026. The resignation was tendered due to personal commitments, and the official was relieved from his duties at the close of business hours on the same day. This change impacts the company's senior management personnel structure within its research and development division.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding the submission of the necessary details.

Mr. Bilakhiya was designated as a Senior Management Personnel of the company via a letter dated April 8, 2026. His resignation marks the cessation of his tenure with the company effective from the specified date in July 2026. The company has confirmed that the resignation was accepted and processed as per the regulatory norms.

The following table summarizes the key details of the management change:

The information regarding this change has been made available on the company's official website. The resignation letter submitted by Mr. Bilakhiya cited his desire to reside with his family in Vadodara as the primary reason for stepping down from his role.

Camlin Fine Sciences Ltd disclosed that its promoters and promoter group have not created any encumbrance on the shares held by them during the financial year ended March 31, 2026. This declaration was submitted to the stock exchanges to confirm compliance with regulatory norms regarding share holdings.

The disclosure was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Ashish Dandekar submitted the declaration on behalf of the promoter group, confirming that no new encumbrances were made other than those already disclosed.

The filing identifies the specific entities and individuals covered under this declaration. The list includes individual promoters as well as corporate entities within the group.

The letter was addressed to the National Stock Exchange of India Ltd, BSE Limited, and the Audit Committee of Camlin Fine Sciences Ltd. The company requested that the information be disseminated on the websites of the exchanges.